Morphological profiling for drug discovery in the era of deep learning
Briefings in Bioinformatics · 23.05.2024 · 25 (4)
DOI: 10.1093/bib/bbae284 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 17.06.2024. Verfasst von Qiaosi Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Calico Life Sciences, South San Francisco, CA 94080, United States. Hauptthemen laut MEDLINE: Deep Learning, Drug Discovery. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, UF AI Catalyst Fund, University of Florida.
Abstract (Originalsprache)
Morphological profiling is a valuable tool in phenotypic drug discovery. The advent of high-throughput automated imaging has enabled the capturing of a wide range of morphological features of cells or organisms in response to perturbations at the single-cell resolution. Concurrently, significant advances in machine learning and deep learning, especially in computer vision, have led to substantial improvements in analyzing large-scale high-content images at high throughput. These efforts have facilitated understanding of compound mechanism of action, drug repurposing, characterization of cell morphodynamics under perturbation, and ultimately contributing to the development of novel therapeutics. In this review, we provide a comprehensive overview of the recent advances in the field of morphological profiling. We summarize the image profiling analysis workflow, survey a broad spectrum of analysis strategies encompassing feature engineering– and deep learning–based approaches, and introduce publicly available benchmark datasets. We place a particular emphasis on the application of deep learning in this pipeline, covering cell segmentation, image representation learning, and multimodal learning. Additionally, we illuminate the application of morphological profiling in phenotypic drug discovery and highlight potential challenges and opportunities in this field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Calico Life Sciences, South San Francisco, CA 94080, United States.
- Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development, University of Florida, Gainesville, FL 32610, United States.
- Department of Computer & Information Science & Engineering, University of Florida, Gainesville, FL 32611, United States.
- J. Crayton Pruitt Family Department of Biomedical Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL 32611, United States.
- Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL 32611, United States.
ORCID-Profile: Qiaosi Tang, Gustavo Seabra, Ruogu Fang, Lina Cui, Yousong Ding, Jiang Bian, Chenglong Li, Hendrik Luesch, Yanjun Li
Förderung
- NIGMS NIH HHS
- UF AI Catalyst Fund
- University of Florida
- NCI NIH HHS
- Bodor Professorship Fund
- NIH HHS
- NCATS NIH HHS
- NIA NIH HHS
Zitieren
APA
Tang, Q., Ratnayake, R., Seabra, G., Jiang, Z., Fang, R., Cui, L., Ding, Y., Kahveci, T., Bian, J., Li, C., Luesch, H., & Li, Y. (2024). Morphological profiling for drug discovery in the era of deep learning. Briefings in Bioinformatics, 25(4). https://doi.org/10.1093/bib/bbae284
Vancouver
Tang Q, Ratnayake R, Seabra G, Jiang Z, Fang R, Cui L, et al. Morphological profiling for drug discovery in the era of deep learning. Briefings in Bioinformatics. 2024;25(4). doi:10.1093/bib/bbae284
BibTeX
@article{Tang2024,
author = {Tang, Qiaosi and Ratnayake, Ranjala and Seabra, Gustavo and Jiang, Zhe and Fang, Ruogu and Cui, Lina and Ding, Yousong and Kahveci, Tamer and Bian, Jiang and Li, Chenglong and Luesch, Hendrik and Li, Yanjun},
title = {Morphological profiling for drug discovery in the era of deep learning},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {4},
doi = {10.1093/bib/bbae284}
}
EUVIMED